Front Cardiovasc Med. 2017 May 30;4:35. doi: 10.3389/fcvm.2017.00035. eCollection 2017.
Hybrid Instantaneous Wave-Free Ratio-Fractional Flow Reserve versus Fractional Flow Reserve in the Real World.
Frontiers in cardiovascular medicine
Kara Shuttleworth, Kristina Smith, Jonathan Watt, Jamie A L Smith, Stephen J Leslie
Affiliations
Affiliations
- Cardiac Unit, Raigmore Hospital, Inverness, UK.
- Department of Diabetes and Cardiovascular Science, The Centre for Health Science, University of the Highlands and Islands, The Centre for Health Science, Inverness, UK.
PMID: 28612008
PMCID: PMC5447668 DOI: 10.3389/fcvm.2017.00035
Abstract
BACKGROUND: The instantaneous wave-free ratio (iFR) is a novel method to assess the ischemic potential of coronary artery stenoses. Clinical trial data have shown that iFR has acceptable diagnostic agreement with fractional flow reserve (FFR), the reference standard for the functional assessment of coronary stenoses. This study compares iFR measurements with FFR measurements in a real world, single-center setting.
METHODS AND RESULTS: Instantaneous wave-free ratio and FFR were measured in 50 coronary artery lesions in 42 patients, with FFR ≤ 0.8 classified as functionally significant. An iFR-only technique, using a treatment cut-off value, iFR ≤ 0.89, provided a classification agreement of 84% with FFR ≤ 0.80. Use of a hybrid iFR-FFR technique, incorporating FFR measurement for lesions within the iFR gray zone of 0.86-0.93, would improve classification agreement with FFR to 94%, with diagnosis achieved without the need for hyperemia in 57% patients.
CONCLUSION: This study in a real-world setting demonstrated good classification agreement between iFR and FFR. Use of a hybrid iFR-FFR technique would achieve high diagnostic accuracy while minimizing adenosine use, compared with routine FFR.
Keywords: angiography; coronary stenosis; fractional flow reserve; functional assessment; instantaneous wave-free ratio
References
- J Am Coll Cardiol. 2013 Apr 2;61(13):1409-20 - PubMed
- J Am Coll Cardiol. 2010 Jun 22;55(25):2816-21 - PubMed
- J Am Coll Cardiol. 2012 May 22;59(21):1915-6; author reply 1917-8 - PubMed
- Circulation. 2006 Jan 24;113(3):446-55 - PubMed
- EuroIntervention. 2013 May 20;9(1):91-101 - PubMed
- J Am Coll Cardiol. 2012 May 22;59(21):1915; author reply 1917-8 - PubMed
- J Am Coll Cardiol. 2014 Apr 8;63(13):1253-61 - PubMed
- Int J Cardiol. 2013 Oct 9;168(4):4070-5 - PubMed
- J Am Coll Cardiol. 2012 Apr 10;59(15):1392-402 - PubMed
- Int J Cardiol. 2015 Nov 15;199:1-7 - PubMed
- EuroIntervention. 2013 Feb 22;8(10):1157-65 - PubMed
- Am Heart J. 2015 Nov;170(5):945-50 - PubMed
- J Am Coll Cardiol. 2012 May 22;59(21):1916-7; author reply 1917-8 - PubMed
- Circ Cardiovasc Interv. 2013 Dec;6(6):654-61 - PubMed
- Circ Cardiovasc Interv. 2014 Aug;7(4):492-502 - PubMed
- J Am Coll Cardiol. 2012 Apr 10;59(15):1403-5 - PubMed
- N Engl J Med. 2017 May 11;376(19):1824-1834 - PubMed
- N Engl J Med. 2009 Jan 15;360(3):213-24 - PubMed
- Circulation. 1995 Dec 1;92(11):3183-93 - PubMed
- BMJ. 2016 Oct 20;355:i5534 - PubMed
- Circ Cardiovasc Interv. 2015 May;8(5):null - PubMed
- Circulation. 2001 Jun 19;103(24):2928-34 - PubMed
Publication Types